Gastrointestinal Cancer

Explore the latest updates, including expert interviews and features

The GI Cancer Channel on VJOncology is supported by Seagen. This supporter has no influence over the production of the content.

Latest videos VJSessions Subtypes Topics Conferences Features Editorial Board

Welcome to the Gastrointestinal Cancer Channel!

Catch up on the latest developments in gastrointestinal cancer with VJOncology, featuring exclusive interviews, podcasts, and expert-led roundtable discussions.

Genomic biomarkers in metastatic colorectal cancer

Subtypes

Gastric Cancer
Colorectal Cancer
Liver Cancer
Bile Duct Cancer
Pancreatic Cancer
0:33
Subgroup analysis of ATTRACTION-5: benefit of nivolumab in G/GEJ advanced + PD-L1-positive tumors
Masanori Terashima • 3 Jun 2023
0:41
Current standard treatment options for pStage III gastric or G/GEJ cancer
Masanori Terashima • 3 Jun 2023
1:11
ATTRACTION-5: nivo + chemo as postoperative adju treatment for pathological stage III G/GEJ cancer
Masanori Terashima • 3 Jun 2023
1:05
Limitations in immune checkpoint inhibitors in treating gastric cancer
Yelena Janjigian • 18 Apr 2023
View All Videos
3:07
FIRE-4: influence of baseline liquid biopsy results in 1L efficacy of FOLFIRI/cetux in RAS-WT mCRC
Sebastian Stintzing • 2 Jun 2023
2:53
The emerging role of MRD in colorectal cancer decision making
Benny Johnson • 17 Apr 2023
1:12
Targeted therapies in metastatic colorectal cancer
Benny Johnson • 17 Apr 2023
0:41
How can immunotherapies successfully target MSS colorectal cancer?
Benny Johnson • 17 Apr 2023
View All Videos
0:31
Will atezolizumab and bevacizumab be the new SOC in high-risk HCC?
Pierce Chow • 18 Apr 2023
3:31
ctDNA linked to RFS in patients with HCC treated with neoadjuvant cemiplimab
Thomas Urban Marron • 16 Apr 2023
1:00
The role of NT219 in enhancing anti-PD-1 efficacy
Ricardo De Azevedo • 17 Apr 2023
6:32
Combination therapies to treat hepatocellular carcinoma
Ghassan Abou-Alfa • 3 Apr 2023
View All Videos
2:52
The effect of futibatinib on hepatic impairment in ICC
Ling Gao • 18 Apr 2023
1:27
Advancements in the treatment of biliary tract cancers
Ghassan Abou-Alfa • 20 Jan 2023
4:50
Management of biliary tract cancers with targeted therapies
Ghassan Abou-Alfa • 20 Jan 2023
2:00
The benefits of liver transplantation in mCRC and intrahepatic CCA
Gonzalo Sapisochin • 19 Jan 2023
View All Videos
2:42
Assessing the heterogeneity of KRAS-mutant pancreatic adenocarcinomas
Bach Ardalan • 2 Jun 2023
0:51
Personalized treatment approaches for patients with KRAS-mutant pancreatic cancer
Bach Ardalan • 2 Jun 2023
1:07
The case for separating G12D mutations in studying KRAS-mutant PDAC
Bach Ardalan • 2 Jun 2023
1:43
Identifying alternative molecular targets using NGS in pancreatic cancer
Antonia Digklia • 24 Mar 2023
View All Videos

Topics

Immuno-Oncology
CAR-T & Cellular Therapy
Trial Updates
Molecular Profiling
Radiotherapy
3:07
FIRE-4: influence of baseline liquid biopsy results in 1L efficacy of FOLFIRI/cetux in RAS-WT mCRC
Sebastian Stintzing • 2 Jun 2023
0:33
Subgroup analysis of ATTRACTION-5: benefit of nivolumab in G/GEJ advanced + PD-L1-positive tumors
Masanori Terashima • 3 Jun 2023
1:11
ATTRACTION-5: nivo + chemo as postoperative adju treatment for pathological stage III G/GEJ cancer
Masanori Terashima • 3 Jun 2023
1:43
Identifying alternative molecular targets using NGS in pancreatic cancer
Antonia Digklia • 24 Mar 2023
View All Videos
0:41
How can immunotherapies successfully target MSS colorectal cancer?
Benny Johnson • 17 Apr 2023
1:12
BASECAMP-1: progress in developing CAR-T cell therapy for solid tumors
Diane Simeone • 4 Apr 2023
2:57
BASECAMP-1: developing Tmod CAR T-cell therapy for solid tumors
Diane Simeone • 4 Apr 2023
1:04
Challenges in developing cellular therapies in solid tumors
Benjamin Schlechter • 21 Jan 2023
View All Videos
3:07
FIRE-4: influence of baseline liquid biopsy results in 1L efficacy of FOLFIRI/cetux in RAS-WT mCRC
Sebastian Stintzing • 2 Jun 2023
0:33
Subgroup analysis of ATTRACTION-5: benefit of nivolumab in G/GEJ advanced + PD-L1-positive tumors
Masanori Terashima • 3 Jun 2023
0:41
Current standard treatment options for pStage III gastric or G/GEJ cancer
Masanori Terashima • 3 Jun 2023
1:11
ATTRACTION-5: nivo + chemo as postoperative adju treatment for pathological stage III G/GEJ cancer
Masanori Terashima • 3 Jun 2023
View All Videos
3:07
FIRE-4: influence of baseline liquid biopsy results in 1L efficacy of FOLFIRI/cetux in RAS-WT mCRC
Sebastian Stintzing • 2 Jun 2023
1:43
Identifying alternative molecular targets using NGS in pancreatic cancer
Antonia Digklia • 24 Mar 2023
0:52
Precision medicine for patients with rare pancreatic malignancies
Dirk Arnold • 23 Mar 2023
3:19
Unmet needs and precision oncology advancements in metastatic GIST
Robin Jones • 4 Apr 2023
View All Videos
1:28
ctDNA testing in pancreatic cancer and other upper GI malignancies
Suneel Kamath • 4 Apr 2023
3:03
The future of radiotherapy as a treatment for pancreatic cancer
Joseph Herman • 28 Mar 2023
4:04
Alliance trials: Combination of modified FOLFIRINOX and radiotherapy for pancreatic cancer
Joseph Herman • 28 Mar 2023
1:56
Limitations of using radiotherapy for patients with pancreatic cancer
Joseph Herman • 28 Mar 2023
View All Videos

Conferences

ASCO GI 2023
ASCO 2022
AACR 2022
ASCO GI 2022
ESMO 2021
ESMO WCGIC 2021
1:07
Updates in colorectal and rectal cancer at ASCO GI 2023
Ardaman Shergill • 26 Jan 2023
1:17
Detecting resistance to treatments in CRC with liquid biopsies
Ardaman Shergill • 26 Jan 2023
1:20
Advances in predicative biomarkers for rectal cancer
Ardaman Shergill • 26 Jan 2023
5:05
Is front-line anti-EFGR therapy essential in RAS-WT mCRC?
Ardaman Shergill • 26 Jan 2023
View All Videos
4:53
Phase I trial of mRNA neoantigen vaccines for pancreatic cancer
Vinod P. Balachandran • 16 Jun 2022
3:17
Development of individualized mRNA neoantigen vaccines for pancreatic cancer
Vinod Balachandran • 16 Jun 2022
1:31
Potential of immunotherapy for pancreatic cancer
Vinod P. Balachandran • 16 Jun 2022
1:13
Next steps for the development of individualised mRNA neoantigen vaccines
Vinod P. Balachandran • 16 Jun 2022
View All Videos
1:42
Effect of microbes on clinical outcomes of neoadjuvant treatment in patients with rectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
4:05
Racial disparities in clinical outcomes for patients with colorectal cancer
Francisco Sanchez-Vega • 10 Apr 2022
1:19
The importance of studying circulating tumor cell lines
Catherine Alix-Panabieres • 12 Apr 2022
1:52
Effect of chemokine-modulating infusion on local infiltration of immune cells into colorectal tumors
Pawel Kalinski • 12 Apr 2022
View All Videos
8:18
The use of ctDNA in patient cancer care
Arvind Dasari • 1 Feb 2022
3:41
CIRCULATE-US: investigating the use of ctDNA to detect MRD
Arvind Dasari • 1 Feb 2022
3:15
Investigating fruquintinib in patients with refractory metastatic CRC
Arvind Dasari • 1 Feb 2022
3:01
Treating patients with gastric cancer with immunotherapy: who will benefit?
Sun Young Rha • 25 Jan 2022
View All Videos
3:01
Genomic landscape of late-stage gastric cancer treated with pembrolizumab
Yelena Y. Janjigian • 28 Sep 2021
3:41
Highlights in gastric cancer from ESMO 2021
Yelena Y. Janjigian • 28 Sep 2021
2:40
DESTINY-Gastric02: 2L T-DXd in HER2+ gastric cancers
Geoffrey Ku • 27 Sep 2021
2:04
Update on the CheckMate649 trial in treatment-naïve GEA
Elizabeth C. Smyth • 21 Sep 2021
View All Videos
2:58
Tislelizumab in patients with unresectable HCC demonstrates durable responses
Ghassan Abou-Alfa • 25 Jun 2021
2:35
Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastases
Firas Baidoun • 7 Jul 2021
1:37
Impact of gender and HPV status on anal squamous cell carcinoma survival
Firas Baidoun • 7 Jul 2021
0:40
1L NALIRIFOX in advanced or metastatic PDAC
Zev Wainberg • 1 Jul 2021
View All Videos

The GI Cancer Channel on VJOncology is supported by Seagen.

This supporter has no influence over the production of the content.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals